Real-World study reveals how schizophrenia patients actually use KarXT
NCT ID NCT07571148
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at health records and insurance claims from nearly 7,000 adults in the U.S. who take KarXT for schizophrenia. Researchers want to understand who gets the drug, how it's used, and how often people need hospital visits. The goal is to see how the medication works in everyday practice, not in a controlled trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Veradigm
Chicago, Illinois, 60654, United States